Recital 4, Regulation (EU) 2024/1161

In forcesince 22 Apr 2024

The European Food Safety Authority (‘the Authority’) concluded in its opinion of 27 September 2023 [EFSA Journal 2023;21(10):8347.] that all three forms of the preparation of Enterococcus lactis NCIMB 10415 are safe for the target species, the consumers and the environment under the proposed conditions of use. It also concluded that the ‘micro-encapsulated form’ and the ‘micro-encapsulated form with shellac’ of that preparation are non-irritant to skin or eyes and that all three forms of the additive are considered a potential respiratory sensitiser. No conclusion could be drawn by the Authority on the potential of the ‘non-coated granulated form’ of that preparation to be skin and eye irritant nor on the skin sensitisation potential of all three forms of the additive. The Authority indicated that there was no need for assessing the efficacy of the preparation of Enterococcus lactis NCIMB 10415 in the context of the renewal of the authorisation as the application for renewal of the authorisation does not include a proposal for amending or supplementing the conditions of use for those species and categories for which there is an authorisation. It further concluded that the efficacy for the new uses can be extrapolated from the previous efficacy studies and that, regarding the compatibility with coccidiostats, the conclusions already reached previously can be extrapolated for the other poultry species and categories at the relevant physiological stage and for the coccidiostats for which an authorisation exists. The Authority did not consider that there is a need for specific requirements of post-market monitoring.